News & Updates
Filter by Specialty:
Prasugrel on par with clopidogrel in reducing stroke recurrence in thrombotic stroke patients
11 Nov 2022
byAudrey Abella
In thrombotic stroke patients at high risk of ischaemic stroke recurrence, prasugrel was as effective as clopidogrel in reducing the composite incidence of ischaemic stroke, MI, and death from other vascular causes, the phase III PRASTRO-III study has shown.
Prasugrel on par with clopidogrel in reducing stroke recurrence in thrombotic stroke patients
11 Nov 2022
AF does not reduce dapagliflozin efficacy in HF patients
10 Nov 2022
byStephen Padilla
The presence of atrial fibrillation (AF) at baseline does not appear to modify the benefits of dapagliflozin, compared with placebo, on symptoms and clinical events in patients with heart failure and preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF), according to a study.
